Takeda Pharmaceutical Company Limited (TKPYY)
-OTC Markets 24.10 May 21, 3:59PM EDT|Pre-Market
:
NaN
| Prev Close: | 24.10 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 20.18 - 27.87 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 31,519 |
|---|
| Market Cap: | 38.05B |
|---|
| P/E (ttm): | 22.82 |
|---|
| EPS (ttm): | 1.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- AMAG says Takeda recalling one batch of Rienso from Swiss markettheflyonthewall.com(Tue, May 21)
- Takeda Pharmaceutical Co Ltd. CEO Discusses F4Q2012 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Takeda tumbles after predicting a drop in next year's earningsat MarketWatch(Thu, May 9)
- Takeda Pharmaceutical Company Limited Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Fiscal Year Ending March 31, 2014PR Newswire(Thu, May 9)
- Takeda to buy Inviragenat theflyonthewall.com(Tue, May 7)
- AMAG Narrows Loss; Maintains ViewZacks(Wed, Apr 24)
- A New Cure for Painkiller Constipationat Motley Fool(Tue, Apr 23)
- Array Presents ARRY-520 DataZacks(Wed, Apr 10)
- Pfizer's Xeljanz Approved in JapanZacks(Mon, Apr 1)
- Apricus Biosciences: A Transformative Year Aheadat Seeking Alpha(Mon, Apr 1)
- Takeda Files Adcetris in JapanZacks(Wed, Mar 27)
- Affymax to Cut 75% of WorkforceZacks(Tue, Mar 19)
- Positive Results on AMAG's FerahemeZacks(Mon, Mar 18)
- Major Setback for Aeterna ZentarisZacks(Tue, Mar 12)
- FDA Action Date for AMAG DrugZacks(Mon, Mar 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.92 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Takeda Pharmaceutical Company Limited, a research-based pharmaceutical company, engages in the manufacture, marketing, and import/export of pharmaceutical drugs worldwide.
View More 
0.34%